SGS Life Sciences Solutions for Brexit
As a pharmaceutical company, you may have uncertainties around the process of the United Kingdom leaving the European Union. With an international network of Life Sciences labs located throughout North America, Europe and Asia, SGS is here to help.
SGS offers a full range of integrated solutions – from preclinical activities to Phase I-IV trials, bioanalytical, R&D, characterization, biosafety, and quality control testing of small and large molecules, raw material products and containers. Whether your manufacturing stays in the UK or moves to another site, we have the capabilities and capacity to ensure that you are ready – no matter the outcome of the Brexit deal.
SGS service highlights
SGS life sciences solutions offer you:
- Lot release testing, including analytical chemistry and microbiology
- Method development and validation
- Stability studies
- Extractables and leachables
- Biopharmaceutical characterization
- Potency assays
- Bioanalysis of large and small molecules
- Impurity determination
- Equipment and IT validation
Laboratories near you
Our global laboratory network provides a local presence in:
- Belgium
- France
- Germany
- Greece
- Italy
- Scotland
- Switzerland
Discover how SGS can help you post-Brexit – contact us today
To find out more about SGS Life Sciences services and post-Brexit testing, fill out the form below: